Back to Search
Start Over
Spatiotemporally co-delivery of triple therapeutic drugs via HA-coating nanosystems for enhanced immunotherapy
- Source :
- Asian Journal of Pharmaceutical Sciences, Vol 16, Iss 5, Pp 653-664 (2021), Asian Journal of Pharmaceutical Sciences
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- There is growing empirical evidence that certain types of chemotherapy and phototherapy trigger immunogenic cell death and enhance the therapeutic anticancer efficacy of genetic immunotherapy. However, the main challenge is spatiotemporally co-delivering different drugs to maximize the therapeutic index of the combination therapy. In this study, a drug delivery system (HTCP-Au/shPD-L1/DOX) was designed with a polysaccharide-wrapped shell and a condensed DNA core. To construct the HTCP-Au vector, dodecyl side chains with a polyethylenimine (PEI) head were grafted onto hyaluronic acid, and AuNPs were grafted via Au-S bonds. During drug loading, PEI arrested shRNA plasmid DNA targeting programmed cell death ligand 1 (shPD-L1) via electrostatic interactions. It also formed a PEI-DNA core that was automatically enclosed when aliphatic hydrocarbons pulled the hyaluronic acid backbone. A hydrophobic interlayer consisting of dodecyl bridge chains between the PEI-DNA core and the hyaluronic acid shell was required to accommodate hydrophobic doxorubicin. In vitro and in vivo assays demonstrated that this core-shell drug delivery system could efficiently load and transport three different drugs and effectively target tumors. Moreover, it could activate the immune system, thereby providing promising therapeutic efficacy against tumor growth and metastasis.<br />Graphical abstract HTCP-Au/shPD-L1/DOX was composed of gold nanoparticles (AuNPs)-modified hyaluronic acid shell, shPD-L1 plasmid core compressed by cationic polyethyleneimine and doxorubicin (DOX) encapsulated in hydrophobic layer. It could target to tumor cells by the CD44 receptor which is over-expressed in tumor microenvironment, followed by drug releasing responsively at 808 nm laser and the low pH in lysosome. Then the PD-L1 gene silencing induced by shPD-L1 and immunogenic cell death effect triggered by DOX and AuNPs will eliminate the tumor synergisticallyImage, graphical abstract
- Subjects :
- PD-L1
Pharmacology
Drug
Polyethylenimine
Hyaluronic acid
media_common.quotation_subject
Pharmaceutical Science
RM1-950
Original Research Paper
chemistry.chemical_compound
Therapeutic index
chemistry
In vivo
Drug delivery
Biophysics
medicine
Immunogenic cell death
Doxorubicin
Immunotherapy
Therapeutics. Pharmacology
media_common
medicine.drug
Subjects
Details
- ISSN :
- 18180876
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Asian Journal of Pharmaceutical Sciences
- Accession number :
- edsair.doi.dedup.....0841a6790825e8f29048f0215303550e